Fine mapping of chromosome 10q deletions in mycosis fungoides and Sezary syndrome: Identification of two discrete regions of deletion at 10q23.33-24.1 and 10q24.33-25.1

Genes Chromosomes and Cancer

Volumn 42, Issue 2, 2005, Pages 184-192

  Wain, E Mary ^a   Mitchell, Tracey J ^a   Russell Jones, Robin ^a   Whittaker, Sean J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2C; G PROTEIN COUPLED RECEPTOR; HELICASE; HOMEODOMAIN PROTEIN; KINESIN; RETINOL BINDING PROTEIN;

ALLELE; ARTICLE; CHROMOSOME 10Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME IDENTIFICATION; CHROMOSOME MAP; CYTOGENETICS; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; MICROSATELLITE MARKER; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; SEZARY SYNDROME;

CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 10; GENES, NEOPLASM; HUMANS; LOSS OF HETEROZYGOSITY; MYCOSIS FUNGOIDES; SEZARY SYNDROME; SKIN NEOPLASMS;

EID: 11844252526     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20115     Document Type: Article

References (43)

1. Alimov A, Li C, Gizatullin R, Fredriksson V, Sundelin B, Klein G, Zabarovsky E, Bergerheim U. 1999. Somatic mutation and homozygous deletion of PTEN/MMAC1 gene of 10q23 in renal cell carcinoma. Anticancer Res 19:3841-3846.
2. Beltinger C, Kurz E, Bohler T, Schrappe M, Ludwig W-D, Debatin K-M. 1998. CD95 (APO-1/Fas) mutations in childhood T-lineage acute lymphoblastic leukaemia. Blood 91:3943-3951.
3. Berger R, Baranger L, Bernheim A, Valensi F, Flandrin G. 1988. Cytogenetics of T-cell malignant lymphoma. Report of 17 cases and review of the chromosomal breakpoints. Cancer Genet Cytogenet 36:123-130.
4. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S. 1998. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248-5257.
5. Bunn PA Jr, Lamberg SI. 1979. Report of the committee on staging and classification of cutaneous T-cell lymphomas. Cancer Treat Rep 63:725-728.
6. Butler MP, Wang SI, Chaganti RSK, Parsons R, Dalla-Favera R. 1999. Analysis of PTEN mutations and deletions in B-cell non-Hodgkin's lymphomas. Genes Chromosomes Cancer 24:322-327.
7. Chernova OB, Somerville RPT, Cowell JK. 1998. A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumours. Oncogene 17:2873-2881.
8. Dereure O, Levi E, Vonderheid EC, Kadin ME. 2002. Infrequent Fas mutations but no bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin. J Invest Dermatol 118:949-956.
9. Eagle LR, Yin X, Brothman AR, Williams BJ, Atkin NB, Prochownik EV. 1995. Mutation of the MXI1 gene in prostate cancer. Nat Genet 95:709-711.
10. Fawole AD, Simpson DJ, Rajagopal R, Elder J, Holland TA, Fryer A, Deakin M, Elder JB, Farrell WE. 2002. Loss of heterozygosity on chromosome 10q is associated with earlier onset sporadic colorectal adenocarcinoma. Int J Cancer 99:829-833.
11. Fraser-Andrews EA, Woolford AJ, Russell-Jones R, Seed PT, Whittaker SJ. 2000. Detection of a peripheral blood T cell clone is an independent prognostic marker in mycosis fungoides. J Invest Dermatol 114:117-121.
12. Fujiwara Y, Hoon DS, Yamada T, Umeshita K, Gotoh M, Sakon M, Nishisho I, Monden M. 2000. PTEN/MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas. Jpn J Cancer Res 91:287-292.
13. Gray IC, Phillips SM, Lee SJ, Neoptolemos JP, Weissenbach J, Spurr NK. 1995. Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res 55:4800-4803
14. Gronbaek K, Straten PT, Ralkiaer E, Ahrenkiel V, Anderson MK, Hansen NE, Zeuthen J, Hou-Jensen K, Guldberg P. 1998. Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood 92:3018-3024.
15. Herbst RA, Weiss J, Ehnis A, Cavenee WK, Arden KC. 1994. Loss of heterozygosity for 10q22-10qter in malignant melanoma progression. Cancer Res 54:3111-3114.
16. Kagan J, Liu J, Stein JD, Wagner SS, Babkowski R, Grossman BH, Katz RL. 1998. Cluster of allele losses within a 2.5 cM region of chromosome 10 in high-grade invasive bladder cancer. Oncogene 16:909-913.
17. Karlbom AE, James CD, Boethius J, Cavenee WK, Collins VP, Nordenskjold M, Larson C. 1993. Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Hum Genet 92:169-174.
18. Karenko L, Kahkonen M, Hyytinen ER, Lindlof M, Ranki A. 1999. Notable losses at specific regions of chromosomes 10q and 13q in the Sezary syndrome detected by comparative genomic hybridization. J Invest Dermatol 112:392-395.
19. Landowski TH, Qu N, Buyuksal I, Painter JS, Dalton WS. 1997. Mutations in the fas antigen in patients with multiple myeloma. Blood 90:4266-4270.
20. Liaw D, Marsh DJ, Li J, Dahia PLM, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R. 1997. Germline mutations of the PTEN gene in Cowden's disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64-67.
21. Limon J, Nedoszytko B, Brozek I, Hellmann A, Zajaczek S, Lubinski J, Mrozek K. 1995. Chromosome aberrations, spontaneous SCE, and growth kinetics in PHA-stimulated lymphocytes of five cases with Sezary syndrome. Cancer Genet Cytogenet 83:75-81.
22. Mao X, Lillington D, Scarisbrick JJ, Mitchell T, Czepulkowski B, Russell-Jones R, Young B, Whittaker SJ. 2002. Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sezary syndrome and mycosis fungoides. Br J Dermatol 147:464-475.
23. Mao X, Lillington DM, Czepulkowski B, Russell-Jones R, Young BD, Whittaker S. 2003. Molecular cytogenetic characterization of Sezary Syndrome. Genes Chromosomes Cancer 36:250-260.
24. Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wilgenbus KK, Deimling A, Poustka A. 1997. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumors. Nat Genet 17:32-39.
25. Nakahara Y, Nagai H, Kinoshita T, Uchida T, Hatano S, Saito H. Mutational analysis of the PTEN gene in non-Hodgkin's lymphoma. Leukaemia 1998;12:1277-1280.
26. Nowell PC, Vonderheid EC, Besa E, Hoxie JA, Moreau L, Finan JB. 1986. The most common chromosome change in 86 chronic B cell or T cell tumors: a 14q32 translocation. Cancer Genet Cytogenet 19:219-227.
27. Peiffer SL, Herzog TJ, Tribune DJ, Mutch DG, Gersell DJ, Goodfellow PJ. 1995. Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. Cancer Res 55:1922-1926.
28. Sakai A, Thieblemont C, Wellmann A, Jaffe ES, Raffeld M. 1998. PTEN gene alterations in lymphoid neoplasms. Blood 92:3410-3415.
29. Scarisbrick JJ, Woolford AJ, Russell-Jones R, Whittaker SJ. 2000. Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN. Blood 95:2937-2942.
30. Scarisbrick JJ, Woolford AJ, Russell-Jones R, Whittaker SJ. 2001. Allelotyping in mycosis fungoides and Sezary Syndrome: Common regions of allelic loss identified on 9p, 10q and 17p. J Invest Dermatol 117:663-670.
31. Scarisbrick JJ, Mitchell TJ, Calonje E, Orchard G, Russell-Jones R, Whittaker SJ. 2003. Microsatellite instability is associated with hypermethylation of the hMLH1 gene and reduced gene expression in mycosis fungoides. J Invest Dermatol 121:894-901.
32. Sieben NLG, ter Haar NT, Cornelisse CJ, Fleuren GJ, Cleton-Jansen A-M. 2000. PCR artifacts in LOH and MSI analysis of microdissected tumor cells. Hum Pathol 31:1414-1419.
33. Singh B, Ittmann MM, Krolewski JJ. 1998. Sporadic breast cancers exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden disease locus. Genes Chromosomes Cancer 21:166-171.
34. So CC, Wong KF, Siu LL, Kwong YL. 2000. Large cell transformation of Sezary syndrome. A conventional and molecular cytogenetic study. Am J Clin Pathol 113:792-797.
35. Speaks SL, Sanger WG, Masih AS, Harrington DS, Hess M, Armitage JO. 1992. Recurrent abnormalities of chromosome bands 10q23-25 in non-Hodgkin's lymphoma. Genes Chromosomes Cancer 5:239-243.
36. Tamiya S, Etoh E-I, Suzushima H, Takatsuki K, Matsuoka M. 1998. Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells. Blood 10:3935-3942.
37. Thangavelu M, Finn WG, Yelavarthi KK, Roenigk HH, Samuelson E, Peterson L, Kuzel TM, Rosen ST. 1997. Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sezary syndrome. Blood 89:3371-3377.
38. Thiagalingam S, Laken S, Willson JKV, Markowitz SD, Kinzler KW, Vogelstein B, Lengauer C. 2001. Mechanisms underlying losses of heterozygosity in human colorectal cancers. Proc Natl Acad Sci USA 98:2698-2702.
39. Weinstock MA and Gardstein B. 1999. Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality. Am J Public Health 89:1240-1244.
40. Whang-Peng J, Bunn PA Jr, Knutsen T, Mathews MJ, Schechter GP, Minna JD. 1982. Clinical implications of cytogenetic studies in cutaneous T-cell lymphoma (CTCL). Cancer 50:1539-1553.
41. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Perez JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, van Vloten WA, Meijer CJ. 1997. EORTC Classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European Organisation for Research and Treatment of Cancer. Blood 90:354-371.
42. Yeh JJ, Marsh DJ, Zedenius J, Dwight T, Delbridge L, Robinson BG, Eng C. 1999. Fine-structure deletion mapping of 10q22-24 identifies regions of loss of heterozygosity and suggests that sporadic follicular thyroid adenomas and follicular thyroid carcinomas develop along distinct neoplastic pathways. Genes Chromosomes Cancer 26:322-328.
43. Zackhcim HS, Amin S, Kashani-Sabet M, McMillan A. 1999. Prognosis in cutaneous T-cell lymphoma by skin stage: Long-term survival in 489 patients. J Am Acad Dermatol 40:418-425.